Pancreatic Cancer Research

ResearcherKarolinska University HospitalActive in the last 2 years

Nikolaos Kartalis

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8003-1787; OpenAlex author ID A5086605052. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
26
Papers, trials and grants by year

2012: 2 papers · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 4 papers · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 14

  1. The European Multidisciplinary Evidence-Based Guideline on Pancreatic Cancer: Methodological Protocol. Co-author DOI 10.1002/gin2.70074↗
  2. Performance of MRI-based surveillance for high-risk individuals for pancreatic cancer. Last author DOI 10.1016/j.ejrad.2025.112275↗
  3. Consistency of a clinical decision support system with molecular tumour board recommendations for tumour sequencing-guided treatment of pancreatic cancer. Co-author DOI 10.1016/j.esmogo.2024.100070↗
  4. CT and MRI of pancreatic cancer: there is no rose without a thorn! Co-author DOI 10.1007/s00330-018-5486-z↗
  5. Radiological assessment of local resectability status in patients with pancreatic cancer: Interreader agreement and reader performance in two different classif… Last author DOI 10.1016/j.ejrad.2018.06.014↗
  6. A Preliminary Report: Radical Surgery and Stem Cell Transplantation for the Treatment of Patients With Pancreatic Cancer. Co-author DOI 10.1097/cji.0000000000000164↗
  7. Impact of delay between imaging and treatment in patients with potentially curable pancreatic cancer. Co-author DOI 10.1002/bjs.10046↗
  8. Multidetector CT of pancreatic ductal adenocarcinoma: Effect of tube voltage and iodine load on tumour conspicuity and image quality. Last author DOI 10.1007/s00330-016-4273-y↗
  9. Diffusion-weighted MR imaging of pancreatic cancer: A comparison of mono-exponential, bi-exponential and non-Gaussian kurtosis models. Co-author DOI 10.1016/j.ejro.2016.04.002↗
  10. A phase I dose escalation trial of AXP107-11, a novel multi-component crystalline form of genistein, in combination with gemcitabine in chemotherapy-naive pati… Co-author DOI 10.1016/j.pan.2016.05.002↗
  11. Short-term Results of a Magnetic Resonance Imaging-Based Swedish Screening Program for Individuals at Risk for Pancreatic Cancer. Co-author DOI 10.1001/jamasurg.2014.3852↗
  12. Computed tomography staging of pancreatic cancer: a validation study addressing interobserver agreement. Last author DOI 10.1016/j.pan.2013.09.004↗
  13. Optimising diffusion-weighted MR imaging for demonstrating pancreatic cancer: a comparison of respiratory-triggered, free-breathing and breath-hold techniques. Co-author DOI 10.1007/s00330-012-2469-3↗
  14. Low tube voltage CT for improved detection of pancreatic cancer: detection threshold for small, simulated lesions. Co-author DOI 10.1186/1471-2342-12-20↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Matthias J. Löhr · 5 shared papers, 2015–2025 · strength 0.62
  2. Raffaella Pozzi Mucelli · 3 shared papers, 2015–2025 · strength 0.50
  3. Carlos Fernández Moro · 2 shared papers, 2024–2025 · strength 0.45
  4. Poya Ghorbani · 2 shared papers, 2024–2025 · strength 0.45
  5. Marco Del Chiaro · 5 shared papers, 2015–2024 · strength 0.43
  6. Louiza Loizou · 6 shared papers, 2012–2018 · strength 0.31
  7. Nils Albiin · 6 shared papers, 2012–2017 · strength 0.28
  8. Miroslav Vujasinović · 1 shared paper, 2025 · strength 0.27
  9. Jan‐Erik Frödin · 2 shared papers, 2016–2024 · strength 0.25
  10. Caroline Sophie Verbeke · 4 shared papers, 2015–2017 · strength 0.22
  11. Linnéa Malgerud · 1 shared paper, 2024 · strength 0.18
  12. Maximilian Kordes · 1 shared paper, 2024 · strength 0.18
  13. Mikael Björnstedt · 1 shared paper, 2024 · strength 0.18
  14. Maria Gustafsson Liljefors · 1 shared paper, 2024 · strength 0.18
  15. Anders Sundin · 3 shared papers, 2012–2016 · strength 0.13
  16. Brigitta Omazic · 2 shared papers, 2016–2017 · strength 0.12
  17. Åke Andrén‐Sandberg · 2 shared papers, 2015–2016 · strength 0.11
  18. Christoph Ansorge · 2 shared papers, 2013–2016 · strength 0.10
  19. Nickolas K. Papanikolaou · 1 shared paper, 2016 · strength 0.06
  20. Srinivas Sanjeevi · 1 shared paper, 2016 · strength 0.06
  21. Marco Del Chiaro · 1 shared paper, 2016 · strength 0.06
  22. Rainer Lothar Heuchel · 1 shared paper, 2017 · strength 0.05
  23. Olle T.H. Ringdén · 1 shared paper, 2017 · strength 0.05
  24. Johan Permert · 1 shared paper, 2017 · strength 0.05
  25. Markus J. Maeurer · 1 shared paper, 2017 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.